Sarah Spencer
Contatto Relazioni con gli Investitori presso VOR BIOPHARMA INC.
Posizioni attive di Sarah Spencer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VOR BIOPHARMA INC. | Contatto Relazioni con gli Investitori | - | - |
| Public Communications Contact | - | - |
Storia della carriera di Sarah Spencer
Precedenti posizioni note di Sarah Spencer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Public Communications Contact | 01/04/2019 | 01/04/2021 |
| GSK PLC | Public Communications Contact | - | - |
Formazione di Sarah Spencer
| State University of New York at Buffalo | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Regno Unito | 2 |
Posizioni
| Public Communications Contact | 3 |
| Undergraduate Degree | 1 |
| Investor Relations Contact | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GSK PLC | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Sarah Spencer
- Esperienza
